This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Covetrus 미래 성장
Future 기준 확인 4/6
주요 정보
50.8%
수익 성장률
50.7%
EPS 성장률
| Healthcare 수익 성장 | 20.8% |
| 매출 성장률 | 6.3% |
| 향후 자기자본 수익률 | 10.6% |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | n/a |
최근 미래 성장 업데이트
Recent updates
수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2024 | 5,385 | 100 | 125 | N/A | 4 |
| 12/31/2023 | 5,084 | 52 | 92 | N/A | 5 |
| 12/31/2022 | 4,795 | 10 | 112 | N/A | 5 |
| 6/30/2022 | 4,649 | -13 | 2 | 60 | N/A |
| 3/31/2022 | 4,621 | -40 | 70 | 126 | N/A |
| 12/31/2021 | 4,575 | -54 | 42 | 102 | N/A |
| 9/30/2021 | 4,575 | -56 | 44 | 104 | N/A |
| 6/30/2021 | 4,539 | -90 | -60 | 2 | N/A |
| 3/31/2021 | 4,376 | -13 | 10 | 72 | N/A |
| 12/31/2020 | 4,339 | -26 | -5 | 53 | N/A |
| 9/30/2020 | 4,225 | -19 | 31 | 80 | N/A |
| 6/30/2020 | 4,117 | -940 | 112 | 154 | N/A |
| 3/31/2020 | 4,100 | -996 | 18 | 58 | N/A |
| 12/31/2019 | 3,976 | -980 | 64 | 103 | N/A |
| 9/30/2019 | 3,871 | -948 | 93 | 130 | N/A |
| 6/30/2019 | 3,776 | 27 | 83 | 113 | N/A |
| 3/31/2019 | 3,772 | 65 | 131 | 157 | N/A |
| 12/29/2018 | 3,778 | 101 | 136 | 158 | N/A |
| 9/30/2018 | 3,791 | 69 | 74 | 94 | N/A |
| 6/30/2018 | 3,776 | 74 | 103 | 127 | N/A |
| 3/31/2018 | 3,649 | 67 | 42 | 64 | N/A |
| 12/30/2017 | 3,580 | 64 | 87 | 108 | N/A |
| 12/31/2016 | 3,353 | 70 | 92 | 105 | N/A |
| 12/26/2015 | 2,978 | 60 | N/A | 96 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: 2NJ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.03%).
수익 vs 시장: 2NJ is forecast to become profitable over the next 3 years, which is considered above average market growth.
고성장 수익: 2NJ is expected to become profitable in the next 3 years.
수익 대 시장: 2NJ's revenue (6.3% per year) is forecast to grow faster than the German market (3.9% per year).
고성장 수익: 2NJ's revenue (6.3% per year) is forecast to grow slower than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: 2NJ's Return on Equity is forecast to be low in 3 years time (10.6%).